FLNA and prostate carcinoma: Given the multi-faceted roles of filamin A, targeting its phosphorylation in different disease may offer potential in alleviating disease phenotypes, for instance in metastatic progression of breast and prostate cancers, compared with a traditional pharmacological inhibition approach which may be unfavourable given filamin A's complex scaffolding of orthogonal actin networks as wells as discrete signalosomes vital for compartmentalised responses to different stimuli.